
Ep90: James Sabry on Partnering Amid Scientific Abundance
The Long Run with Luke Timmerman
00:00
Gene Therapy
We view proteins and biologics and anna bodies as standard therapy. I believe we're going to view genetic surgery, genetic engineering and gean therapy as standard therapy 30 or forty yearsw. There's a lot of technology development that has to happen to make it effective and safe between now and then. If you really want to become an important health care company 30 or forty years from now, start putting those foundational building ction place to day.
Transcript
Play full episode